Royalty Pharma PLC acquires biopharmaceutical royalties and funds innovation by partnering with companies to co-fund clinical trials and product launches in exchange for future royalties. Its portfolio spans multiple therapeutic areas.

Royalty Pharma Logo

About Royalty Pharma

Royalty Pharma PLC acquires biopharmaceutical royalties and funds innovation in the biopharmaceutical industry. The company partners with innovators to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and also acquires existing royalties from original innovators. Its portfolio includes royalties on marketed therapies and development-stage product candidates across therapeutic areas such as rare disease, cancer, neuroscience, infectious disease, hematology, and diabetes.

Address

110 East 59th Street,
New York, 10022
United States

Year founded

2020

Number of employees

0-100

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Life Sciences Tools & Services

Report inaccurate data

Request an update to help us keep the brand up-to-date.

One API,
Millions of Logos

Get Started Contact Us
One API, Millions of Logos